Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (4): 587-592. doi: 10.19723/j.issn.1671-167X.2023.04.003

Previous Articles     Next Articles

Effect of vitamin D3 on mild cognitive impairment in type 2 diabetic mice and its possible mechanism

Lei BAO1,*(),Xia-xia CAI2,Ming-yuan ZHANG2,Lei-lei REN2   

  1. 1. Department of Nutrition, Peking University International Hospital, Beijing 102206, China
    2. Department of Nutrition and Food Hygiene, School of Public Health, Capital Medical University, Beijing 100069, China
  • Received:2020-10-12 Online:2023-08-18 Published:2023-08-03
  • Contact: Lei BAO E-mail:baolei6230@163.com
  • Supported by:
    the National Natural Science Foundation of China(81803211);the Peking University International Hospital Research Funds(YN2018QX01)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To investigate the effect of vitamin D3 on mild cognitive impairment in type 2 diabetic mice and explore its possible mechanism. Methods: Male db/db mice were randomly divided into 4 groups: the diabetes mellitus (DM) group, the low dose [250 IU/(kg·d)], medium dose [500 IU/ (kg·d)] and high dose [1 000 IU/(kg·d)] vitamin D3 intervention groups. The db/m mice were enrolled as the normal control group. The mice in vitamin D3 groups were gavaged with corresponding concentration of vitamin D3 in corn oil, and the mice in the normal control group and the DM group were gavaged with corn oil. After being fed for 16 weeks, fasting blood glucose of mice in each group was measured at the end of 0, 4, 8 and 16 weeks, and the new object recognition experiment was conducted at the end of 16 weeks. At the end of the experiment, the hippocampi and cortices of mice in each group were collected, and the concentration of 5-hydroxytryptamine (5-HT) and interleukin-18 (IL-18) in the hippocampal tissues of mice in each group were determined by enzyme linked immunosorbent assay (ELISA). Immunohistochemical staining was used to observe the expression of nucleotide binding oligomerization domain-like receptor family pyrin domain-containing protein 3 (NLRP3) in the hippocampal tissues of the mice. Results: Compared with the normal control group, the fasting blood glucose of mice in DM group was significantly increased (P < 0.01). The exploration and discrimination index (DI) in the new object recognition experiment were significantly decreased (P < 0.05). The concentrations of 5-HT in the hippocampal tissues of mice were significantly decreased (P < 0.01). The concentrations of IL-18 in cortical tissues of mice were significantly increased (P < 0.01) and the positive expression of NLRP3 in the hippocampal tissues was higher. However, compared with the DM group, the fasting blood glucose of mice was significantly decreased in the medium and high dose vitamin D3 groups at the end of 8 and 16 weeks (P < 0.05 or P < 0.01). The exploration and DI of mice in the new object recognition experiment were significantly increased in high dose vitamin D3 group (P < 0.05). The concentrations of 5-HT in hippocampal tissues were significantly increased (P < 0.01) and the concentrations of IL-18 in cortical tissues were significantly decreased in the medium and high dose vitamin D3 groups (P < 0.01). The positive expression of NLRP3 in hippocampal tissues was reduced in all the vitamin D3 groups. Conclusion: Vitamin D3 might reduce the inflammatory response by inhibiting the activity of NLRP3, and thus ameliorating mild cognitive impairment in type 2 diabetic mice.

Key words: Vitamin D3, Type 2 diabetes mellitus, Cognitive dysfunction

CLC Number: 

  • R591.44

Figure 1

Effects of vitamin D3 on fasting blood glucose in mice (n=12) * * P < 0.01, compared with the normal control rats. # P < 0.05, ## P < 0.01, compared with the DM control rats. FBG, fasting blood glucose; N, normal; DM, diabetes mellitus; LVD3, low dose vitamin D3 group; MVD3, medium dose vitamin D3 group; HVD3, high dose vitamin D3 group."

Table 1

Effects of vitamin D3 on the new object recognition experiment in mice"

Group n Number of exploration times, n Exploration time/s DI/%
N 12 7.80±0.85 10.52±1.11 69.34±6.12
DM 12 1.50±0.60* 1.16±0.45* 19.51±7.02*
LVD3 12 2.90±0.92 3.39±1.29 21.36±11.02
MVD3 12 3.20±0.84 3.24±0.87 29.37±10.04
HVD3 12 3.90±0.69# 4.70±1.08# 54.27±8.11#

Figure 2

Effects of vitamin D3 on 5-HT of hippocampus in mice (n=12) * * P < 0.01, compared with the normal control rats. ## P < 0.01, compared with the DM control rats. 5-HT, 5-hydroxytryptamine; Other abbreviations as in Figure 1."

Figure 3

Effects of vitamin D3 on IL-18 of cortex in mice (n=12) * * P < 0.01, compared with the normal control rats. ## P < 0.01, compared with the DM control rats. IL-18, interleukin-18; Other abbreviations as in Figure 1."

Figure 4

Effects of vitamin D3 on the protein expression of NLRP3 of hippocampus in mice (immunoperoxidase-indirect method) Abbreviations as in Figure 1."

1 Cho NH , Shaw JE , Karuranga S , et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138, 271- 281.
doi: 10.1016/j.diabres.2018.02.023
2 Xu Y , Wang L , He J , et al. 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310 (9): 948- 959.
doi: 10.1001/jama.2013.168118
3 Jia J , Wang F , Wei C , et al. The prevalence of dementia in urban and rural areas of China[J]. Alzheimers Dement, 2014, 10 (1): 1- 9.
doi: 10.1016/j.jalz.2013.01.012
4 De Felice FG , Ferreira ST . Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease[J]. Diabetes, 2014, 63 (7): 2262- 2272.
doi: 10.2337/db13-1954
5 Ott A , Stolk RP , van Harskamp F . Diabetes mellitus and the risk of dementia: The Rotterdam Study[J]. Neurology, 1999, 53 (9): 1937- 1942.
doi: 10.1212/WNL.53.9.1937
6 Bitel CL , Kasinathan C , Kaswala RH , et al. Amyloid-β and tau pathology of Alzheimer' s disease induced by diabetes in a rabbit animal model[J]. J Alzheimers Dis, 2012, 32 (2): 291- 305.
doi: 10.3233/JAD-2012-120571
7 Coll RC , Robertson AA , Chae JJ , et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases[J]. Nat Med, 2015, 21 (3): 248- 255.
doi: 10.1038/nm.3806
8 Heneka MT , Kummer MP , Stutz A , et al. NLRP3 is activated in Alzheimer' s disease and contributes to pathology in APP/PS1 mice[J]. Nature, 2013, 493 (7434): 674- 678.
doi: 10.1038/nature11729
9 Schroder K , Zhou R , Tschopp J . The NLRP3 inflammasome: A sensor for metabolic danger?[J]. Science, 2010, 327 (5963): 296- 300.
doi: 10.1126/science.1184003
10 Yu ZW , Zhang J , Li X , et al. A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications[J]. Life Sci, 2020, 240, 117138.
doi: 10.1016/j.lfs.2019.117138
11 Holick MF . The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention[J]. Rev Endocr Metab Disord, 2017, 18 (2): 153- 165.
doi: 10.1007/s11154-017-9424-1
12 Christakos S , Hewison M , Gardner DG , et al. Vitamin D: Beyond bone[J]. Ann N Y Acad Sci, 2013, 1287 (1): 45- 58.
doi: 10.1111/nyas.12129
13 Bevins RA , Besheer J . Object recognition in rats and mice: A one-trial non-matching-to-sample learning task to study recognition memory[J]. Nat Protoc, 2006, 1 (3): 1306- 1311.
doi: 10.1038/nprot.2006.205
14 Mortimer JA , Borenstein AR , Ding D , et al. High normal fasting blood glucose is associated with dementia in Chinese elderly[J]. Alzheimers Dement, 2010, 6 (6): 440- 447.
doi: 10.1016/j.jalz.2010.03.017
15 Li X , Song D , Leng SX . Link between type 2 diabetes and Alzheimer's disease: From epidemiology to mechanism and treatment[J]. Clin Interv Aging, 2015, 10, 549- 560.
16 Oosterwerff MM , Eekhoff EM , Heymans MW , et al. Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: A population-based study[J]. Clin Endocrinol (Oxf), 2011, 75 (5): 608- 613.
doi: 10.1111/j.1365-2265.2011.04110.x
17 Nikooyeh B , Neyestani TR , Farvid M , et al. Daily consumption of vitamin D- or vitamin D+ calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: A randomized clinical trial[J]. Am J Clin Nutr, 2011, 93 (4): 764- 771.
doi: 10.3945/ajcn.110.007336
18 Elkassaby S , Harrison LC , Mazzitelli N , et al. A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 106 (3): 576- 582.
doi: 10.1016/j.diabres.2014.08.030
19 Sadiya A , Ahmed SM , Carlsson M , et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: A randomized controlled double-blinded clinical trial[J]. Eur J Clin Nutr, 2015, 69 (6): 707- 711.
doi: 10.1038/ejcn.2014.251
20 张悦, 张小年, 张皓. 颅脑创伤后认知相关神经递质变化的研究进展[J]. 中国康复理论与实践, 2018, 24 (1): 71- 75.
21 Goodwill AM , Szoeke C . A systematic review and meta-analysis of the effect of low vitamin D on cognition[J]. J Am Geriatr Soc, 2017, 65 (10): 2161- 2168.
doi: 10.1111/jgs.15012
22 Chen RH , Zhao XH , Gu Z , et al. Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults[J]. Endocrine, 2014, 45 (2): 319- 324.
doi: 10.1007/s12020-013-0041-9
23 Weber KS , Nowotny B , Strassburger K , et al. The role of markers of low-grade inflammation for the early time course of glycemic control, glucose disappearance rate, and β-cell function in recently diagnosed type 1 and type 2 diabetes[J]. Diabetes Care, 2015, 38 (9): 1758- 1767.
doi: 10.2337/dc15-0169
24 Lee YJ , Han SB , Nam SY , et al. Inflammation and Alzheimer' s disease[J]. Arch Pharm Res, 2010, 33 (10): 1539- 1556.
doi: 10.1007/s12272-010-1006-7
25 Mokhtari-Zaer A , Hosseini M , Salmani H , et al. Vitamin D3 attenuates lipopolysaccharide-induced cognitive impairment in rats by inhibiting inflammation and oxidative stress[J]. Life Sci, 2020, 253, 117703.
doi: 10.1016/j.lfs.2020.117703
26 Davis BK , Wen H , Ting JP . The inflammasome NLRs in immunity, inflammation, and associated diseases[J]. Annu Rev Immunol, 2011, 29, 707- 735.
doi: 10.1146/annurev-immunol-031210-101405
[1] CHEN Ping,LI Ze-ming,GUO Yi,SUN Xin-ying,Edwin B. FISHER. To explore medication adherence of patients with type 2 diabetes mellitus using the latent profile analysis based on the Big Five personality theory [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 530-535.
[2] Jiang XIE,Fei LI. Association of sleep overlap syndrome with type 2 diabetes in a cross-sectional study [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 252-255.
[3] LIU Kai-ning, MENG Huan-xin, HOU Jian-xia. Influence of vitamin D receptor FokⅠ polymorphism on expression of CYP24A1 in periodontal cells [J]. Journal of Peking University(Health Sciences), 2018, 50(1): 13-19.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd